GOSSAMER BIO, INC.

GOSS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017
Operating Activities
Net Income $-6.8M
Depreciation & Amortization
Depreciation $0
Amortization
Stock-Based Compensation $32.0K
Net Cash from Operating Activities $-5.7M
Investing Activities
Capital Expenditures
Business Acquisitions
Net Cash from Investing Activities
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $6.0M
Net Change in Cash $255.0K
Free Cash Flow
← Newer Page 2 of 2 Older →